NGAL has recently been described as a useful biomarker for lower respiratory tract infections33 and the associated mortality34 and may also serve as an indicator of an ongoing risk for renal injury,35 which is common in patients with pulmonary disorders.36 This evidence concerns the gene LCN2 and lung disorder.